These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 27178440)

  • 21. Olfactomedin-4 is a glycoprotein secreted into mucus in active IBD.
    Gersemann M; Becker S; Nuding S; Antoni L; Ott G; Fritz P; Oue N; Yasui W; Wehkamp J; Stange EF
    J Crohns Colitis; 2012 May; 6(4):425-34. PubMed ID: 22398066
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antagonistic crosstalk between NF-κB and SIRT1 in the regulation of inflammation and metabolic disorders.
    Kauppinen A; Suuronen T; Ojala J; Kaarniranta K; Salminen A
    Cell Signal; 2013 Oct; 25(10):1939-48. PubMed ID: 23770291
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epigenetic silencing of olfactomedin-4 enhances gastric cancer cell invasion via activation of focal adhesion kinase signaling.
    Guo LL; He ZC; Yang CQ; Qiao PT; Yin GL
    BMB Rep; 2015 Nov; 48(11):630-5. PubMed ID: 26303970
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of olfactomedin 4+ cells in prostate and urethral-tube epithelium during murine postnatal development and in adult mice.
    Li H; Chaitankar V; Cui L; Chen W; Chin K; Zhu J; Liu W; Rodgers GP
    Sci Rep; 2023 Jun; 13(1):10290. PubMed ID: 37357228
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low expression of olfactomedin 4 correlates with poor prognosis in smoking patients with non-small cell lung cancer.
    Su W; Luo L; Wu F; Lai Z; Li X; Xie Z; Tang Z; Yang Z; Liang R
    Hum Pathol; 2015 May; 46(5):732-8. PubMed ID: 25771901
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Olfactomedin-related proteins 4 (OLFM4) expression is involved in early gastric carcinogenesis and of prognostic significance in advanced gastric cancer.
    Jang BG; Lee BL; Kim WH
    Virchows Arch; 2015 Sep; 467(3):285-94. PubMed ID: 26070873
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma levels of OLFM4 in normals and patients with gastrointestinal cancer.
    Clemmensen SN; Glenthøj AJ; Heebøll S; Nielsen HJ; Koch C; Borregaard N
    J Cell Mol Med; 2015 Dec; 19(12):2865-73. PubMed ID: 26416558
    [TBL] [Abstract][Full Text] [Related]  

  • 28. OLFM4 Expression in Ductal Carcinoma In Situ and in Invasive Breast Cancer Cohorts by a SWATH-Based Proteomic Approach.
    Valo I; Raro P; Boissard A; Maarouf A; Jézéquel P; Verriele V; Campone M; Coqueret O; Guette C
    Proteomics; 2019 Nov; 19(21-22):e1800446. PubMed ID: 31318138
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Olfactomedin 4 (OLFM4) expression is associated with nodal metastases in esophageal adenocarcinoma.
    Suzuki L; Ten Kate FJC; Gotink AW; Stoop H; Doukas M; Nieboer D; Spaander MCW; van Lanschot JJB; van Wijnhoven BPL; Koch AD; Bruno MJ; Looijenga LHJ; Biermann K
    PLoS One; 2019; 14(7):e0219494. PubMed ID: 31283789
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stimulus-selective crosstalk via the NF-κB signaling system reinforces innate immune response to alleviate gut infection.
    Banoth B; Chatterjee B; Vijayaragavan B; Prasad MV; Roy P; Basak S
    Elife; 2015 Apr; 4():. PubMed ID: 25905673
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High expression of olfactomedin-4 is correlated with chemoresistance and poor prognosis in pancreatic cancer.
    Ohkuma R; Yada E; Ishikawa S; Komura D; Ishizaki H; Tamada K; Kubota Y; Hamada K; Ishida H; Hirasawa Y; Ariizumi H; Satoh E; Shida M; Watanabe M; Onoue R; Ando K; Tsurutani J; Yoshimura K; Yokobori T; Sasada T; Aoki T; Murakami M; Norose T; Ohike N; Takimoto M; Izumizaki M; Kobayashi S; Tsunoda T; Wada S
    PLoS One; 2020; 15(1):e0226707. PubMed ID: 31923206
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pathogenic Vibrio activate NLRP3 inflammasome via cytotoxins and TLR/nucleotide-binding oligomerization domain-mediated NF-kappa B signaling.
    Toma C; Higa N; Koizumi Y; Nakasone N; Ogura Y; McCoy AJ; Franchi L; Uematsu S; Sagara J; Taniguchi S; Tsutsui H; Akira S; Tschopp J; Núñez G; Suzuki T
    J Immunol; 2010 May; 184(9):5287-97. PubMed ID: 20348425
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Olfactomedin 4 marks a subset of neutrophils in mice.
    Alder MN; Mallela J; Opoka AM; Lahni P; Hildeman DA; Wong HR
    Innate Immun; 2019 Jan; 25(1):22-33. PubMed ID: 30537894
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The olfactomedin-4 positive neutrophil has a role in murine intestinal ischemia/reperfusion injury.
    Levinsky NC; Mallela J; Opoka AM; Harmon K; Lewis HV; Zingarelli B; Wong HR; Alder MN
    FASEB J; 2019 Dec; 33(12):13660-13668. PubMed ID: 31593636
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNA-146b improves intestinal injury in mouse colitis by activating nuclear factor-κB and improving epithelial barrier function.
    Nata T; Fujiya M; Ueno N; Moriichi K; Konishi H; Tanabe H; Ohtake T; Ikuta K; Kohgo Y
    J Gene Med; 2013; 15(6-7):249-60. PubMed ID: 23813877
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Olfm4 deletion enhances defense against Staphylococcus aureus in chronic granulomatous disease.
    Liu W; Yan M; Sugui JA; Li H; Xu C; Joo J; Kwon-Chung KJ; Coleman WG; Rodgers GP
    J Clin Invest; 2013 Sep; 123(9):3751-5. PubMed ID: 23908114
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genomic loss of miR-486 regulates tumor progression and the OLFM4 antiapoptotic factor in gastric cancer.
    Oh HK; Tan AL; Das K; Ooi CH; Deng NT; Tan IB; Beillard E; Lee J; Ramnarayanan K; Rha SY; Palanisamy N; Voorhoeve PM; Tan P
    Clin Cancer Res; 2011 May; 17(9):2657-67. PubMed ID: 21415212
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of cells expressing OLFM4 and LGR5 mRNA by in situ hybridization in the yolk sac and small intestine of embryonic and early post-hatch chicks.
    Zhang H; Wong EA
    Poult Sci; 2018 Feb; 97(2):628-633. PubMed ID: 29155957
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NF-kappaB signaling. Many roads lead to madrid.
    Dixit V; Mak TW
    Cell; 2002 Nov; 111(5):615-9. PubMed ID: 12464174
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epithelial NEMO links innate immunity to chronic intestinal inflammation.
    Nenci A; Becker C; Wullaert A; Gareus R; van Loo G; Danese S; Huth M; Nikolaev A; Neufert C; Madison B; Gumucio D; Neurath MF; Pasparakis M
    Nature; 2007 Mar; 446(7135):557-61. PubMed ID: 17361131
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.